Edico Genome Inc.
Powering up genome analysis
This article was originally published in Start Up
Executive Summary
The $1,000 genome is closer to a $1,130 genome when computing costs are included, according to Edico Genome Inc. The start-up thinks it has a solution to the problem, in the form of its DRAGEN chip, which has been optimized to run genome analysis at a high rate of efficiency; instead of 24 hours, a single chip can analyze genome data in about 20 minutes.
You may also be interested in...
Homology Medicines Inc.
Gene editing has made a great many headlines of late, and one could be forgiven for thinking the field was saturated, but Homology Medicines Inc. offers something new. Its platform relies on a different mechanism, known as homologous recombination, and the start-up's management team believes the approach can get around some of the potential limitations found in other gene-editing technologies.
X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc. spun out from Sanofi to develop compounds that target the CXCR4/CXCL12 receptor pathway to restore immune cell surveillance against cancer.
IO Combos By The Numbers
Over the past five years, pharma companies have cast an increasingly wide research net in search of cancer immunotherapy drug combinations that can help patients who have failed monotherapies.